J. Myers

发表

Cardiovascular outcomes among HIV-infected veterans receiving atazanavir

P. Sax, J. LaFleur, A. Bress, 2017, AIDS.

Systematic review of renal and bone safety of the antiretroviral regimen efavirenz, emtricitabine, and tenofovir disoproxil fumarate in patients with HIV infection

R. Bedimo, L. Rosenblatt, J. Myers, 2016, HIV clinical trials.

Combination antiretroviral therapy toxicities: a comparison between patients and health care professionals.

B. Gazzard, M. Bower, M. Nelson, 2011, Journal of acquired immune deficiency syndromes.

Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: a systematic review and meta-analysis.

L. N. Valenti, K. Clément, M. Karsdal, 2021, Journal of hepatology.

Real-World Assessment of Renal and Bone Safety among Patients with HIV Infection Exposed to Tenofovir Disoproxil Fumarate-Containing Single-Tablet Regimens

A. Villasis-Keever, E. Nkhoma, L. Rosenblatt, 2016, PloS one.

Tenofovir-Associated Bone Adverse Outcomes among a US National Historical Cohort of HIV-Infected Veterans: Risk Modification by Concomitant Antiretrovirals

P. Tebas, J. LaFleur, A. Bress, 2018, Infectious Diseases and Therapy.

Tolerability of central nervous system symptoms among HIV-1 infected efavirenz users: analysis of patient electronic medical record data

M. Broder, E. Chang, T. Bentley, 2015, AIDS care.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance

L. N. Valenti, C. Trautwein, S. Cockell, 2021, JHEP reports : innovation in hepatology.

Atazanavir Plus Cobicistat: Week 48 and Week 144 Subgroup Analyses of a Phase 3, Randomized, Double-Blind, Active-Controlled Trial§

J. Gallant, G. Moyle, H. Cao, 2017, Current HIV research.